J. Trosman

发表

L. Garrison, M. P. Douglas, P. Neumann, 2018, Science.

Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)

M. P. Douglas, A. Slavotinek, K. Phillips, 2019, Genetics in Medicine.

Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients

W. Gradishar, A. Benson, J. Trosman, 2019, Current Treatment Options in Oncology.

Radiology as the Point of Cancer Patient and Care Team Engagement: Applying the 4R Model at a Patient's Breast Cancer Care Initiation.

R. Carlos, M. Simon, Mikele M. Bunce, 2016, Journal of the American College of Radiology : JACR.

Care for a Patient With Cancer As a Project: Management of Complex Task Interdependence in Cancer Care Delivery.

W. Gradishar, B. Rapkin, I. Gareen, 2016, Journal of oncology practice.

Cost of cancer: there is more to it than containing chemotherapy costs.

J. Trosman, C. Weldon, J. Schink, 2012, Oncology.

Payer Decision-Making for Next Generation Sequencing-Based Genetic Tests: Insights from cell-free DNA prenatal genetic screening

M. P. Douglas, Andrew P. Dervan, K. Phillips, 2017 .

Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening

M. P. Douglas, Andrew P. Dervan, K. Phillips, 2016, Genetics in Medicine.

Payer coverage policies for multigene tests

M. P. Douglas, Andrew P. Dervan, K. Phillips, 2017, Nature Biotechnology.

Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.

M. P. Douglas, R. Kelley, A. Kurian, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Do hospitals in a large metropolitan area utilize published breast cancer care practices and guidelines?

W. Gradishar, M. Simon, D. Ansell, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Process improvement in breast cancer care: Is mammography volume associated with a greater need for process improvement?

D. Ansell, J. Trosman, C. Weldon, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

4R COVID-19 Toolkit for Patient Self-Management of Mild or Moderate COVID-19 symptoms

J. Trosman, C. Weldon, B. James, 2021, SSRN Electronic Journal.

Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs.

M. P. Douglas, K. Phillips, J. Trosman, 2019, JAMA.

Company Profile: Center for Business Models in Healthcare.

J. Trosman, C. Weldon, 2013, Personalized medicine.

Fostering a High-Functioning Team in Cancer Care Using the 4R Oncology Model: Assessment in a Large Health System and a Blueprint for Other Institutions

L. Sakoda, J. Velotta, J. Trosman, 2022, JCO oncology practice.

Availability and payer coverage of BRCA1/2 tests and gene panels

M. P. Douglas, K. Phillips, J. Trosman, 2015, Nature Biotechnology.

Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages

T. Kolevska, M. Reed, T. Sundaresan, 2021, JAMA network open.

A Learning Health System Approach to Cancer Survivorship Care Among LGBTQ+ Communities

B. Rapkin, J. Trosman, C. Weldon, 2022, JCO oncology practice.

Genomic sequencing: assessing the health care system, policy, and big-data implications.

Kathryn A Phillips, M. Pletcher, M. P. Douglas, 2014, Health affairs.

Biomarker testing in non-small cell lung cancer (NSCLC): An assessment of current practices in precision oncology in the community setting—A trial of the ECOG-ACRIN cancer research group (EAQ161CD).

B. Rapkin, J. Sicks, K. Weaver, 2021 .

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

A. Rademaker, E. Perez, W. Gradishar, 2014, Journal of the National Cancer Institute.

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

M. P. Douglas, R. Kelley, A. Kurian, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Barriers to the use of personalized medicine in breast cancer.

W. Gradishar, A. Benson, Al B Benson, 2012, Journal of oncology practice.

Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)

M. P. Douglas, A. Slavotinek, K. Phillips, 2019, Genetics in Medicine.

Private Payer Coverage Policies for Whole Exome Sequencing (WES) in Pediatric Patients: Trends Over Time and Analysis of Evidence Cited

S. Parker, M. P. Douglas, A. Slavotinek, 2018, Genetics in Medicine.

Private Payer Coverage Policies for Whole Exome Sequencing (WES) in Pediatric Patients: Trends Over Time and Analysis of Evidence Cited

S. Parker, M. P. Douglas, A. Slavotinek, 2018, Genetics in Medicine.

Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

Kathryn A Phillips, R. Kelley, K. Phillips, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.

K. Phillips, J. Trosman, Stephanie L. Van Bebber, 2010, Journal of oncology practice.

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.

W. Gradishar, A. Benson, J. Trosman, 2013, Journal of comparative effectiveness research.

Association of Community Cancer Centers: Institution-Directed Quality Improvement of Genetic Counseling and Testing for Community Oncology Patients with Breast Cancer

L. Shivakumar, J. Klemp, J. Trosman, 2023, Oncology Issues.

Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.

T. Kolevska, M. Reed, T. Sundaresan, 2020, JCO oncology practice.

Age-based disparities in telehealth use in an urban, underserved population in cancer and pulmonary clinics: A need for policy change

J. Fathi, S. Nyenhuis, J. Trosman, 2022, Journal of the American Association of Nurse Practitioners.

The economic value of personalized medicine tests: what we know and what we need to know

Kathryn A Phillips, Peter Neumann, Su-Ying Liang, 2013, Genetics in Medicine.

Health technology assessment and private payers's coverage of personalized medicine.

K. Phillips, J. Trosman, Stephanie L. Van Bebber, 2011, The American journal of managed care.

New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare.

M. P. Douglas, K. Phillips, J. Trosman, 2018, JCO precision oncology.

Health technology assessment and private payers' coverage of personalized medicine.

K. Phillips, J. Trosman, Stephanie L. Van Bebber, 2011, Journal of oncology practice.

Capacity building for assessing new technologies: approaches to examining personalized medicine in practice.

D. Marshall, K. Phillips, S. Knight, 2010, Personalized medicine.

Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants

Grace A Lin, M. P. Douglas, K. Phillips, 2021, Journal of community genetics.

Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.

John B. Watkins, M. P. Douglas, K. Phillips, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Genetic counselors' experience with reimbursement and patient out‐of‐pocket cost for multi‐cancer gene panel testing for hereditary cancer syndromes

M. P. Douglas, K. Phillips, M. Scheuner, 2022, Journal of genetic counseling.

Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond.

A. Benson, M. Mulcahy, J. Trosman, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

"What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.

Kathryn A Phillips, Deborah A Marshall, M. P. Douglas, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy

M. P. Douglas, A. Kurian, K. Phillips, 2023, Health affairs scholar.

US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).

L. Hindorff, J. Berg, B. Gelb, 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Alan Balch, John Watkins, Massimo Cristofanilli, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Supportive oncology and survivorship care: Initial impact of the Coleman Supportive Oncology Collaborative.

F. Penedo, S. Garcia, W. Dale, 2017 .

Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings

M. P. Douglas, A. Kurian, K. Phillips, 2021, Journal of Genetic Counseling.

Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non–Safety-Net Centers

A. Benson, W. Gradishar, B. Rapkin, 2021, JCO oncology practice.

The economic value of personalized medicine tests: what we know and what we need to know

M. P. Douglas, P. Neumann, K. Phillips, 2013, Genetics in Medicine.

Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening

M. P. Douglas, K. Phillips, P. Deverka, 2016, Genetics in Medicine.

BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer.

W. Gradishar, K. Doll, J. Trosman, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Timing of genetic testing relative to breast cancer surgery.

W. Gradishar, J. Trosman, C. Weldon, 2010 .

Promoting patient health maintenance with cancer care planning at diagnosis and during treatment: baseline data of the Coleman Supportive Oncology Collaborative (CSOC).

W. Gradishar, A. Benson, J. Trosman, 2020 .

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

John B. Watkins, W. Gradishar, A. Benson, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.